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An increasing number of women with cystic fibrosis (CF)
are surviving to reproductive age and this number is likely
to increase as more sophisticated treatments are developed.
Frequently these women now wish to have children and,
unlike male sufferers of cystic fibrosis, their fertility is, in
general, unimpaired. Although the first reported case of
pregnancy (1) appeared to cause significant deterioration in
the mother, many women with CF have now completed
successful pregnancies. Pregnancy in the more severely
affected patient may carry significant risk but the risk is
currently dicult to quantify and specific risk factors are
poorly understood. Previous studies (2,3) have suggested
that pregnancy in patients with a forced expiratory volume
in 1 sec (FEV1 ) of less than 50% predicted is associated
with a poor outcome, but successful pregnancies have been
reported in patients with an FEV1 as low as 38% predicted
(3). Other factors such as % ideal body weight and
microbiology have not previously been shown to correlate
with outcome.
We have reviewed the notes of all patients with an FEV1
550% predicted who had been followed up during
pregnancy at the Royal Brompton Hospital in the last 15
years to see whether any new predictive factors could be
identified. Twelve patients in total were identified. We
compared this group to 19 patients with a pre-pregnancy
FEV1450% predicted who were followed up during the
same time period (see Table 1). In line with previous reports,
the patients with poor respiratory function fared less well.
In the group with a pre-pregnancy FEV1450% predicted
(group 1) the mean duration of pregnancy was shorter (29?9
weeks vs. 37?6 weeks) and they required more intravenous
antibiotics and spent longer in hospital (3?8 weeks vs. 0?8
weeks). However the mean decline in lung function during
pregnancy was less (mean % loss 1?6 vs. 7?6) which may
reflect closer follow-up and earlier intervention. Differences
are not statistically significant but numbers are small.
Forty-five percent of patients in group 1 required a
caesarean section compared to 25% in group 2. FourReceived 29 March 2000 and accepted in revised form 9 June 2000.
Correspondence should be addressed to: Dr S.J. Tanser, 2
Edgcumbe Court, Osborne Road, Plymouth, PL3 4BS, U.K. E-
mail: sjtanser@yahoo.com
0954-6111/00/101004+03 $35?00/0patients from group 1 died during pregnancy. These cases
were examined in detail to see whether there were any
factors that could have predicted this adverse outcome.
Case reports
CASE 1
This 30-year-old woman was diagnosed aged 3 months as
suffering from cystic fibrosis (genotype DF508 / G542X).
Pseudomonas aeruginosa was first isolated at age 17 years
and she was found to have Burkholderia cepacia at age 27.
She had had two previous pneumothoraces, was pancreatic
insucient (requiring daily pancreatic enzymes) and had
had an embolization for haemoptysis 2 years prior to
conception. The pregnancy was planned. At the time of
conception her FEV1 was 34% predicted and she weighed
63 kg. At 12 weeks of gestation she suffered a massive
haemoptysis for which she required embolization. She
initially did well but 1 week later suffered a second
haemoptysis and underwent repeat embolization. Unfortu-
nately she then had a third haemoptysis associated with
cardiac arrest from which she could not be resuscitated.
CASE 2
Cystic fibrosis (genotype DF508/R117H) was diagnosed at
age 2 years. She was pancreatic insucient and sputum
cultures first grew Burkholderia cepacia at age 19. She had
had a previous miscarriage at 14 weeks. At time of
conception, aged 27, FEV1 was 32% predicted. Five
months into her pregnancy she developed a severe infective
exacerbation requiring intravenous antibiotics and oxygen
therapy. She partially recovered from this remaining on
home oxygen but 2 weeks later was readmitted with an
admission PaO2 of 5?8 kPa and a PaCO2 of 6?1 kPa.
Treatment with intravenous antibiotics, steroids and non-
invasive ventilation was instituted but she went on to
develop acute pancreatitis. At 26 weeks she was transferred
to the obstetric unit where she underwent elective caesarean
section under epidural anaesthesia in a semi-sitting position
whilst using non-invasive ventilation. Despite a successful
delivery of a live baby she continued to deteriorate and# 2000 HARCOURT PUBLISHERS LTD
TABLE 1.
Group 1 — FEV1550% predicted Group 2 — FEV1450% predicted
Number 12 19
Mean start weight kg (SD) 50?2 (7?35) 54?9 (8?31)
Mean weight gain kg (SD) 5?59 (3?98) 4?27 (5?13)
Range of pre-pregnancy %FEV1 22–48 57–104
Mean % loss FEV1(SD) 1?6 (7?01) 7?6 (11?34)
Maternal deaths in pregnancy 4 0
Fetal deaths 2 1
Mean gestation (SD) 29?9 (7?7) 37?6 (6?06)
Mean no. IV’s (range) 1?9 (0–6) 0?47 (0–4)
Mean time in hospital 3?8 weeks 0?8 weeks
Number CS 5/12 5/19
NIPPV*/Oxygen during pregnancy 3 (2 live births, 3 maternal deaths) 0
2 year survival 7/12 (58%) 19/19 (100%)
Bacteria isolated—Pseudomonas 6/12 12/19
Burkholderia 4/12 1/19
Staphylococcus 3/12 5/19
Haemophilus 1/12 7/19
Nil 0 1/19
Results displayed as mean (standard deviation). *Non-invasive positive pressure ventilation.
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overwhelming sepsis and respiratory failure.
CASE 3
Cystic fibrosis (genotype DF508/DF508) was diagnosed at
1 month of age. She was always poorly compliant with
treatment and first grewPseudomonas aeruginosa at age 16.
There was chronic colonization with Staphylococcus aureus
and Burkholderia cepacia was isolated at age 20. Pregnancy
(aged 23) was not planned. At the first antenatal visit FEV1
was 37% predicted. She required hospitalization early in
pregnancy for an infective exacerbation and following a
second admission at 10 weeks required home oxygen. At 20
weeks she was readmitted and required intravenous
antibiotics, steroids and non-invasive ventilation. Despite
maximal therapy she continued to deteriorate with poor
nutritional status and respiratory function. Therapeutic
abortion was considered but a rapid deterioration was
followed by a spontaneous abortion at 23 weeks of
gestation and she died 2 h later from respiratory failure.
CASE 4
Cystic fibrosis was diagnosed at 2 months. Pseudomonas
aeruginosa was isolated in her teens but she never became
colonized with Burkholderia cepacia. Aged 26 she became
pregnant with her first child. At that time her FEV1 was
25% predicted. She had a stormy pregnancy with increas-
ingly frequent courses of intravenous antibiotics and spent
the last weeks of her pregnancy in hospital before having a
caesarean section at 34 weeks for increasing respiratorydistress. She subsequently made a good recovery and 2
years later, against medical advice became pregnant again.
At the start of this pregnancy FEV1 was 22% predicted.
She experienced respiratory diculties much earlier in this
pregnancy but declined termination. By 22 weeks of
gestation she was hypercarbic and hypoxic and non-
invasive ventilation was instituted. She continued to
deteriorate and also became increasingly malnourished.
At 26 weeks she underwent emergency caesarean section for
worsening respiratory distress. A live female infant was
delivered but the mother became septicaemic from a
respiratory infection and, despite all efforts, died within
48 h of delivery.
Discussion
Although pre-pregnancy lung function remains an impor-
tant predictor of outcome, in our group of patients several
patients with very poor lung function (FEV1 25%
predicted) had successful pregnancies and were alive 2
years later. There was no mean difference in weight (49?5 vs.
50?6 kg) or body mass index (18?5 vs. 18?5) in those patients
with an FEV1 550% predicted who died compared to
those who survived. Three out of the four patients who died
were colonized with Burkholderia cepacia. One other
patient from group 1 who was colonized with Burkholderia
cepacia died of respiratory failure within 2 years of giving
birth. The only other patient in our series who was
colonized with Burkholderia cepacia had a pre-pregnancy
FEV1 of 4100% predicted. She completed a successful
pregnancy. Colonization with Burkholderia cepacia has
been found not to affect decline in pulmonary function but
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patients (4). A literature search found only two reports in
the literature of pregnancy occurring in patients colonized
with Burkholderia cepacia. One patient (3) had a therapeu-
tic abortion at 18 weeks for fetal malformation (diaphrag-
matic hernia and pulmonary hypoplasia). This was thought
to be naturally occurring and unrelated to the antibiotics
she had received during her pregnancy (ciprofloxacin,
flucloxacillin, azlocillin and gentamicin). The other patient
colonized with Burkholderia cepacia died 10 days after a
caesarean section for respiratory failure (5).
In conclusion, % predicted FEV1 remains an important
predictor for complications during pregnancy. However,
successful pregnancy can occur even in patients with a
FEV1 as low as 25% predicted. In our series, patients
colonized with Burkholderia cepacia had a very poor
outcome and it may be that the reduced long-term survival
seen in adults colonized with Burkholderia cepacia is
accelerated by the relative immunosuppression of preg-
nancy. This area clearly needs more study and may have
major implications for counselling.References
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